Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Single Center Experience Study with Pembrolizumab in Patients with BRAF Mutant Negative Metastatic Melanoma

Single Center Experience Study with Pembrolizumab in Patients with BRAF Mutant Negative... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Facultatis Medicae Naissensis de Gruyter

Single Center Experience Study with Pembrolizumab in Patients with BRAF Mutant Negative Metastatic Melanoma

Loading next page...
 
/lp/de-gruyter/single-center-experience-study-with-pembrolizumab-in-patients-with-EmTi85bJXk
Publisher
de Gruyter
Copyright
© 2019 Ivica Pejčić, et al., published by Sciendo
ISSN
2217-2521
eISSN
2217-2521
DOI
10.2478/afmnai-2018-0028
Publisher site
See Article on Publisher Site

Abstract

Journal

Acta Facultatis Medicae Naissensisde Gruyter

Published: Dec 1, 2018

There are no references for this article.